Pfizer, Inc. (NYSE: PFE) has sweetened its bid for AstraZeneca (NYSE: AZN), in what it is calling its "final proposal."Under ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE